Posttransplant lymphoproliferative disorders in renal allograft recipients: Report of 53 cases of a French multicenter study

Transplant International

Volumn 13, Issue SUPPL. 1, 2000, Pages

  Caillard, Sophie ^a   Lachat, Virginie ^b   Moulin, Bruno ^a   Hiesse, C ^c   Charpentier, B ^c   Dantal, J ^d   Soulilou, J P ^d   Buchler, M ^d   Lebranchu, Y ^d   Garnier, J L ^d   Touraine, J L ^d   Alamartine, E ^d   Berthoux, F ^d   Rivalan, J ^d   Le Pogamp, P ^d   Bourbigot, B ^d   Deteix, P ^d   Renoult, E ^d   Kessler, M ^d   Morelon, E ^e   Kreis, H ^e   Bedrossian, J ^f   Legendre, C ^f   Woelh Jaegle, M L ^d   Wolf, Ph ^d   Loirat, C ^g   Antoine, C ^h   Glotz, D ^h   Cochat, Y ^d   Bayle, F ^d   Vialtel, P ^d   Noel, C ^d   Tanter, Y ^d   Rifle, G ^d   Rostaing, L ^d   Durand, D ^d   Rebibou, J M ^d   Chalopin, J M ^d   Etienne, I ^d   Godin, M ^d   Hurault De Ligny, B ^d   Niaudet, P ^e   Caillard, S ^d   Moulin, B ^d   Lachat, V ^d   Dahmane, D ⁱ   Lang, Ph ⁱ   more..

^a HÔPITAL CIVIL   (France)

^b JT)   (France)

^c BICÊTRE HOSPITAL   (France)

^d Hôpital Necker ^*

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g HÔPITAL ROBERT DEBRÉ   (France)

^h HÔPITAL BROUSSAIS   (France)

ⁱ HENRI MONDOR HOSPITAL   (France)

Author keywords

Chemotherapy; Posttransplant lymphoproliferative disorders; Renal transplantation

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOTRANSPLANTATION; ARTICLE; B CELL LYMPHOMA; CHILD; CLINICAL TRIAL; FEMALE; FRANCE; GRAFT REJECTION; HUMAN; IMMUNOPHENOTYPING; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; REGISTER; T CELL LYMPHOMA; TIME;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; GRAFT REJECTION; HUMANS; IMMUNOPHENOTYPING; KIDNEY TRANSPLANTATION; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REGISTRIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 18044378433     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2000.tb02067.x     Document Type: Article

References (17)

1. Fischer A, Blanche S, Le Bidois J, Bordigoni P, Garnier JL, Niaudet P, Morinet F, Le Deist F, Fischer AM, Griscelli C, Hirn M (1991) Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324: 1451-1456
2. Frizzera G, Hanto DW, Gajl Peczalska KJ (1981) Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41: 4262-4279
3. Garnier JL, Berger F, Betuel H, Vuillaume M, Chapuis-Cellier C, Blanc N, Faure JL, Dubernard JM, Lenoir G, Touraine JL (1989) Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation. Nephrol Dial Transplant 4: 818-823
4. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons LS (1985) Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 39: 461-472
5. Hiesse C, Rieu P, Kriaa F, Larue JR, Goupy C, Neyrat N, Charpentier B (1997) Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period. Transplant Proc 29: 831-833
6. Ho M (1991) Epstein-Barr virus infection after transplantation. In: Transplantation and clinical immunology: virus and transplantation. Elsevier Science, Amsterdam, pp 229-236
7. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler R (1995) Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85: 552-565
8. Morrison VA, Dunn DL, Manivel JC, Gajl-Peczalska KJ, Peterson BA (1994) Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 97: 14-23
9. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J (1988) The pathology of posttransplant lymphoproliferative disorders accuring in the setting of cyclosporine A - prednisone immunosupression. Am J Pathol 133: 173-192
10. Opelz G (1996) Are post-transplant lymphomas inevitable. Nephrol Dial Transplant 11: 1952-1954
11. Opelz G, Henderson R (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342: 1514-1516
12. Opelz G, Schwarz V, Wujciak T (1995) Analysis of non Hodgkin's lymphomas in organ transplant recipients. Transplant Rev: 231-240
13. Penn I (1991) The changing pattern of posttransplant malignancies. Transplant Proc 23: 1101-1103
14. Penn I (1996) Cancers in cyclosporine-treated vs azathioprine-treated patients. Transplant Proc 28: 876-878
15. Pirsch JD, Stratta RJ, Sollinger HW, Hafez GR, D'Allessandro AM, Kalayoglu M, Belzer FO (1989) Treatment of severe Epstein-Barr virus induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation. Am J Med 86: 241-244
16. Starzl TE, Porter KA, Iwatsuki S, Rosenthal JT, Shaw JBW, Atchison RW, Nalesnik MA, Ho M, Griffith BP, Hakala TR, Hardesty RL, Jaffe R (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1: 583-587
17. Swinnen JL, Mullen M, Carr TJ, Costanzo MR, Fisher RI (1995) Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 86: 3333-3340